Mark Newman, Author at Endocrine News

Growth Issues

Growth Spurt: How Pegvisomant Could Be a Promising Solution to a Big Problem

An excess of growth hormone in infancy leads to the rare yet confounding phenomenon of X-linked acrogigantism, which is known to be resistant to conventional pituitary tumor treatments in the pediatric population. However, new data suggests that pegvisomant could not only be a treatment option for these patients, but it could also improve quality-of-life measures....

Endocrine Society Awards Baxter Prize to Innovator in Endocrine Drug Discovery

R. Scott Struthers, PhD, has been awarded the Endocrine Society’s John D. Baxter Prize for Entrepreneurship for his contributions to drug discovery and development programs for endocrine diseases, the Society announced on January 25. The John D. Baxter Prize for Entrepreneurship was established to recognize the extraordinary achievement of bringing an idea, product, service, or...

Meet the 2023 Endocrine Society Laureates: Tasnim Ahsan, MRCP, FRCP, FCPS, Recipient of the International Excellence in Endocrinology Award

International Excellence in Endocrinology Award Tasnim Ahsan, MRCP, FRCP, FCPS Ahsan is the professor emerita at the Jinnah Postgraduate Medical Centre and the founding dean of the Medicell Institute of Diabetes Endocrinology & Metabolism in Karachi, Pakistan. She is an internationally renowned clinician and educator who has contributed to the establishment and growth of the...

Growth Issues

Sex, Race, and Measuring Tape: Health Disparities and Growth Hormone Deficiency

Racial and gender disparities in healthcare begin early — including among children who could benefit from treatment for short stature. New research seems to show that white children — especially boys — are offered growth hormone stimulation tests at a significantly higher rate than girls or Black and Hispanic children. The racial, ethnic, and gender...

Growth Issues

Leveling Up: Pediatric Growth Hormone Deficiency Treatment Advances Show Promise

As the desire for a less frequently administered growth hormone treatment intensifies, clinicians are looking to researchers for the latest data on safety and efficacy. Luckily, as more studies are undertaken patients and clinicians may soon have a wealth of options. Since 1985, children with growth hormone deficiency (GHD) have been prescribed somatropin – recombinant...

Meet the 2023 Endocrine Society Laureates: Beverly M.K. Biller, MD, Recipient of the Sidney H. Ingbar Distinguished Service Award

Sidney H. Ingbar Distinguished Service Award Beverly M.K. Biller, MD A professor of medicine at Harvard Medical School and a physician at Massachusetts General Hospital in Boston, Mass., Biller has been a dedicated and tireless leader of the Endocrine Society for more than a quarter century, deeply impacting the Society and the field of endocrinology....

Meet the 2023 Laureates: Myles Brown, MD, and Márta Korbonits, MD, PhD, DSc, FRCP

Gerald D. Aurbach Award for Outstanding Translational Research This annual award recognizes outstanding contributions to research that accelerates the transition of scientific discoveries into clinical applications. This year, the award has two worthy recipients, Myles Brown, MD; and Márta Korbonits, MD, PhD, DSc, FRCP. Myles Brown, MD Brown is the Emil Frei III Professor of...

President's Viewpoint

Advance Your Career by Volunteering

As we each consider how to make the most of 2023, I hope you will take a few moments to ponder your role in the Endocrine Society and ways to maximize your membership. Getting involved in our activities can be very rewarding, both personally and professionally. In the past two decades, I have been fortunate...